Home TMU Sitemap FAQ Links
正體中文
Home Ongoing Clinical Trials
Ongoing Clinical Trials

Institution
Principal Investigator
Protocol Title
Keyword
TMU-JIRB No. Protocol Title Institution / Principal Investigator dictionary.testing.TypeOfStudy dictionary.testing.PhasesOfClinicalTrialsForDrugs
N202603034 Randomised, placebo-controlled, double-blind, parallel-group Phase II study to evaluate the efficacy and safety of oral BI 3000202 in patients with moderate to severe systemic lupus erythematosus (SLE) New Drug Phase Ⅱ
N202603035 A Phase 1, Randomized, Double-blind, Placebo-controlled, Dose-Escalation Study to Evaluate the Safety and Tolerability of Stemis™ Administered Intravenously in Elderly Subjects with Mild to Moderate Frailty Syndrome New Drug Phase Ⅰ
N202603036 A Phase 1/2 Study of Linvoseltamab in Patients with Relapsed or Refractory Systemic Light Chain Amyloidosis New Drug Phase Ⅰ
N202603045 Pain of Levator Ani Enthesis: A Prospective study on the Efficacy of Oral Corticosteroid New Drug (New Indication) Academic Research
N202603064 OCT-Guided Intelligent Tissue Recognition System for Intra-abdominal Abscess Drainage: Development of a Minimally Invasive Interventional Catheter Based on Optical Coherence Tomography and Machine Learning New Medical Device NA
N202603066 Efficacy and safety of NNC0487-0111 s.c. once-weekly in participants with overweight or obesity, and obstructive sleep apnoea not treated with positive airway pressure (AMAZE 3) New Drug Phase Ⅲ
N202603067 Efficacy and safety of NNC0487-0111 s.c. once-weekly in participants with overweight or obesity, and obstructive sleep apnoea treated with positive airway pressure (AMAZE 4) New Drug Phase Ⅲ
N202603077 Clinical validation of image-based heart rate variability measurement software for diverse populations New Medical Device NA
1 2 40 41 42 43 44 45 46 51 52 / 52

TOP